Filing Details
- Accession Number:
- 0001225208-22-000614
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 18:05:45
- Reporting Period:
- 2022-01-06
- Accepted Time:
- 2022-01-07 18:05:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204551 | A Michael Mussallem | One Edwards Way Irvine CA 92614 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-06 | 45,050 | $21.76 | 233,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-06 | 300 | $125.17 | 232,752 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-01-06 | 12,500 | $0.00 | 220,252 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2022-01-06 | 12,600 | $124.45 | 207,652 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-01-06 | 19,650 | $123.49 | 188,002 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-06 | 12,500 | $0.00 | 3,247,787 | No | 4 | G | Indirect | By Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Indirect | By Living Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2022-01-06 | 45,050 | $0.00 | 45,050 | $21.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 180,200 | 2015-06-14 | 2022-05-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 371,720 | Indirect | 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.
- This transaction was executed in multiple trades at prices ranging from $125.07 to $125.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $124.00 to $124.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $122.99 to $123.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
